Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial

Sauer, 2004, Preoperative versus postoperative chemoradiotherapy for rectal cancer, N Engl J Med, 351, 1731, 10.1056/NEJMoa040694 Gerard, 2006, Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203, J Clin Oncol, 24, 4620, 10.1200/JCO.2006.06.7629 Bosset, 2006, Chemotherapy with preoperative radiotherapy in rectal cancer, N Engl J Med, 355, 1114, 10.1056/NEJMoa060829 Roh, 2009, Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03, J Clin Oncol, 27, 5124, 10.1200/JCO.2009.22.0467 Sebag-Montefiore, 2009, Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial, Lancet, 373, 811, 10.1016/S0140-6736(09)60484-0 van Gijn, 2011, Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial, Lancet Oncol, 12, 575, 10.1016/S1470-2045(11)70097-3 Rödel, 2003, Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer, J Clin Oncol, 21, 3098, 10.1200/JCO.2003.02.505 Rödel, 2007, Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer, J Clin Oncol, 25, 110, 10.1200/JCO.2006.08.3675 Schmiegel, 2008, Update S3-guideline colorectal cancer 2008, Z Gastroenterol, 46, 799, 10.1055/s-2008-1027726 2002 Quirke, 2009, Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial, Lancet, 373, 821, 10.1016/S0140-6736(09)60485-2 Dworak, 1997, Pathological features of rectal cancer after preoperative radiochemotherapy, Int J Colorectal Dis, 12, 19, 10.1007/s003840050072 2012 Aschele, 2011, Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial, J Clin Oncol, 29, 2773, 10.1200/JCO.2010.34.4911 Gerard, 2010, Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2, J Clin Oncol, 28, 1638, 10.1200/JCO.2009.25.8376 Roh, 2011, The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04, Proc Am Soc Clin Oncol, 29 Rich, 2004, Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy, J Clin Oncol, 22, 2214, 10.1200/JCO.2004.08.009 Hofheinz, 2012, Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial, Lancet Oncol, 10.1016/S1470-2045(12)70116-X Valentini, 2008, Evidence and research in rectal cancer, Radiother Oncol, 87, 449, 10.1016/j.radonc.2008.05.022 Nagtegaal, 2002, Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control, J Clin Oncol, 20, 1729, 10.1200/JCO.2002.07.010 Fernandez-Martos, 2010, J Clin Oncol, 28, 859, 10.1200/JCO.2009.25.8541 Chua, 2010, Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial, Lancet Oncol, 11, 241, 10.1016/S1470-2045(09)70381-X